Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$1.49B |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$423M |
| 3 |
SLB Ltd
SLB
|
+$408M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$340M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUX
176
DELISTED
Luxottica Group
LUX
| $46.5M | 0.06% |
748,003
-65,069
| -8% | -$4.04M |
|
177
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $46.3M | 0.06% |
1,532,959
+44,182
| +3% | +$1.34M |
|
178
Prestige Consumer Healthcare
PBH
$2.38B
| $46.1M | 0.06% |
1,365,876
-113,466
| -8% | -$4.35M |
|
179
AAR Corp
AIR
$5.59B
| $44.2M | 0.06% |
1,002,891
-41,361
| -4% | -$1.72M |
|
180
Mid-America Apartment Communities
MAA
$15.4B
| $43.5M | 0.06% |
477,246
-8,456
| -2% | -$765K |
|
181
Texas Instruments
TXN
$252B
| $43.3M | 0.06% |
416,526
+98,728
| +31% | +$10.7M |
|
182
Plexus
PLXS
$6.72B
| $43.1M | 0.06% |
721,723
+21,993
| +3% | +$1.35M |
|
183
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $43M | 0.06% |
528,205
+31,269
| +6% | +$2.66M |
|
184
Nomura Holdings
NMR
$28.3B
| $42.4M | 0.06% |
7,243,383
-865,201
| -11% | -$5.36M |
|
185
PayPal
PYPL
$48.9B
| $42.2M | 0.06% |
555,976
+132,292
| +31% | +$10.5M |
|
186
MSC Industrial Direct
MSM
$6.89B
| $41.9M | 0.06% |
457,350
-139,429
| -23% | -$12.9M |
|
187
Glacier Bancorp
GBCI
$6.42B
| $41.7M | 0.06% |
1,085,870
-628,736
| -37% | -$24.8M |
|
188
Darling Ingredients
DAR
$9.64B
| $41.2M | 0.05% |
2,379,328
+67,836
| +3% | +$1.23M |
|
189
Qualcomm
QCOM
$155B
| $41.1M | 0.05% |
741,544
+146,152
| +25% | +$9.31M |
|
|
NEX
190
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $40.7M | 0.05% |
+2,748,825
| New | +$45M |
|
191
Charles River Laboratories
CRL
$11.2B
| $40.4M | 0.05% |
378,620
-57,408
| -13% | -$6.19M |
|
192
iShares Global Tech ETF
IXN
$8.32B
| $40M | 0.05% |
1,516,050
+319,986
| +27% | +$8.62M |
|
193
Gilead Sciences
GILD
$162B
| $39.8M | 0.05% |
528,459
+85,685
| +19% | +$6.81M |
|
194
Revvity
RVTY
$12.6B
| $39.6M | 0.05% |
522,528
-30,527
| -6% | -$2.36M |
|
195
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $39.2M | 0.05% |
886,280
+183,424
| +26% | +$8.32M |
|
196
CONMED
CNMD
$1.39B
| $38.6M | 0.05% |
609,267
-6,611
| -1% | -$395K |
|
|
WDR
197
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $37.8M | 0.05% |
1,872,731
-56,867
| -3% | -$1.2M |
|
198
Range Resources
RRC
$9.38B
| $37M | 0.05% |
+2,543,188
| New | +$38M |
|
199
Bristol-Myers Squibb
BMY
$133B
| $36.5M | 0.05% |
577,081
-5,132
| -0.9% | -$330K |
|
|
MNDT
200
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $35.6M | 0.05% |
2,101,812
-1,484
| -0.1% | -$23.9K |
|
Similar funds
Ken Fisher's Q1 2018 Portfolio in Review
As of Q1 2018, Ken Fisher held 991 positions worth $75.4B, down 1.5% from $76.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q1 2018 filing shows 69 new, 261 increased, 401 reduced and 162 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B. The largest sale was Barclays ETN+ FI Enhanced Global High Yield ETN, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q1 2018 buy was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B.
- Ken Fisher added most to SLB Ltd in Q1 2018, an estimated $408M increase.
- Ken Fisher's biggest Q1 2018 reduction was Barclays ETN+ FI Enhanced Global High Yield ETN, cutting an estimated $1.59B.
- Ken Fisher fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $123M.
- Ken Fisher's ten largest holdings make up 26% of its $75.4B portfolio in Q1 2018.
- Ken Fisher opened 69 new positions and closed 162 in Q1 2018.
- Ken Fisher's portfolio value fell 1.5% quarter-over-quarter to $75.4B.
Based on Fisher Asset Management's 13F filing for Q1 2018, filed 19 Apr 2018.